A 3D screening approach identifies the compound epitajixanthone hydrate as a new inhibitor of cancer cell growth and invasion.

MLA

Yang, Sheng-Xiang, et al. “A 3D Screening Approach Identifies the Compound Epitajixanthone Hydrate as a New Inhibitor of Cancer Cell Growth and Invasion.” Anti-Cancer Drugs, vol. 31, no. 9, Oct. 2020, pp. 890–99. EBSCOhost, https://doi.org/10.1097/CAD.0000000000000873.

APA

Yang, S.-X., Xiao, J.-F., Liu, T.-K., Huang, Z.-D., Li, X., Chen, Y.-M., & Yang, X.-L. (2020). A 3D screening approach identifies the compound epitajixanthone hydrate as a new inhibitor of cancer cell growth and invasion. Anti-Cancer Drugs, 31(9), 890–899. https://doi.org/10.1097/CAD.0000000000000873

Chicago

Yang, Sheng-Xiang, Jing-Fang Xiao, Ting-Kai Liu, Ze-Diao Huang, Xiang Li, Ye-Miao Chen, and Xiao-Long Yang. 2020. “A 3D Screening Approach Identifies the Compound Epitajixanthone Hydrate as a New Inhibitor of Cancer Cell Growth and Invasion.” Anti-Cancer Drugs 31 (9): 890–99. doi:10.1097/CAD.0000000000000873.